Skip to main content
PW Medtech Group Limited logo

PW Medtech Group Limited — Investor Relations & Filings

Ticker · 1358 ISIN · KYG7306W1087 LEI · 894500L18EYHNJR6VJ41 HKEX Manufacturing
Open in API
Filings indexed 783 across all filing types
Latest filing 2024-01-05 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 1358

About PW Medtech Group Limited

http://www.pwmedtech.com

PW Medtech Group Limited is a medical device company engaged in the research, development, production, and sale of advanced infusion therapy products. The company's core portfolio includes specialized infusion sets and related accessories, such as non-PVC and DEHP-free infusion systems, precision filter infusion sets, light-resistant infusion sets, and safety IV catheters. Operating primarily in China, India, the Americas, and Africa, the Group emphasizes patient and clinician safety. Key innovations include positive pressure needleless connectors designed to prevent blood backflow and contamination, and safety-engineered devices utilizing double-layer tubing (TPU/PVC) and high-precision filtration to mitigate needlestick injuries and adverse infusion reactions.

Recent filings

Filing Released Lang Actions
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2023
Regulatory Filings Classification · 95% confidence The document is a monthly return report submitted to the Hong Kong Exchanges and Clearing Limited regarding movements in securities for PW Medtech Group Limited. It details movements in authorized and issued shares, confirms compliance with listing rules, and provides information about share capital and securities issued. The document is a regulatory submission related to share capital movements and confirmations, not a full financial report, earnings release, or management discussion. It is a regulatory filing reporting share capital and securities movements under the Exchange Listing Rules, specifically a monthly return for equity issuers. Therefore, it fits best under the category of Regulatory Filings (RNS). The document length (6271 characters) and content confirm it is not merely an announcement but a formal regulatory submission, yet it does not contain financial statements or detailed financial analysis to qualify as an Annual Report or Interim Report.
2024-01-05 English
RENEWAL OF CONTINUING CONNECTED TRANSACTIONS IN RELATION TO PURCHASE OF MEDICAL DEVICES MOLDS AND COMPONENTS
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the renewal of continuing connected transactions related to the purchase of medical devices molds and components. It references the Listing Rules, annual caps, and internal control systems for connected transactions. The content is focused on describing the terms, parties, pricing policies, and regulatory implications of the renewed agreement. It does not contain financial statements, earnings data, or detailed financial analysis. It is a regulatory announcement about a specific transaction and its compliance with listing rules rather than a full financial report or earnings release. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2024-01-01 English
DISCLOSEABLE TRANSACTION DEEMED DISPOSAL OF 2.51% EQUITY INTEREST IN A SUBSIDIARY AS A RESULT OF NEW ISSUANCE OF SHARES OF A SUBSIDIARY
Capital/Financing Update Classification · 95% confidence The document is an announcement by PW Medtech Group Limited regarding a discloseable transaction involving a deemed disposal of equity interest in a subsidiary due to new share issuance. It details an investment agreement, share transfer, share subscription, and changes in shareholding structure. The content focuses on a capital transaction and financing event, including terms, conditions, and implications under listing rules. There is no indication that this is a full annual or interim report, audit report, earnings release, or other types of filings. The document is a detailed announcement about a financing-related transaction, fitting the Capital/Financing Update category.
2023-12-22 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2023
Regulatory Filings Classification · 95% confidence The document is a monthly return report detailing movements in securities, specifically authorized and issued shares, share options, and confirmations related to securities issued by PW Medtech Group Limited. It is addressed to the Hong Kong Exchanges and Clearing Limited and references compliance with the Exchange Listing Rules. The document does not contain financial statements, earnings data, or management discussion but focuses on share capital movements and confirmations of compliance. It is a regulatory submission related to share capital and securities movements rather than a financial report or announcement of voting results. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory compliance documents that do not fit other specific categories.
2023-12-04 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2023
Regulatory Filings Classification · 95% confidence The document is a monthly return for an equity issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules, detailing movements in securities for the month ended 31 October 2023. It includes detailed information on movements in authorized/registered share capital, issued shares, share options, and confirmations related to securities issuance. The document is a regulatory submission to the Hong Kong Exchanges and Clearing Limited and does not contain financial performance data, earnings, or management discussion. It is a regulatory compliance filing reporting share capital and share movements rather than a financial report or announcement of voting results. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-11-06 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2023
Share Issue/Capital Change Classification · 95% confidence The document is a monthly return report detailing movements in securities, specifically authorized and issued shares, share options, and confirmations related to securities issued by PW Medtech Group Limited. It is addressed to the Hong Kong Exchanges and Clearing Limited and references compliance with the Exchange Listing Rules. The content focuses on share capital movements and confirmations rather than financial performance, management changes, or earnings. The document is about share capital and securities movements, which aligns with announcements regarding share issues or capital changes. It is not a full financial report, earnings release, or management report. Therefore, the most appropriate classification is Share Issue/Capital Change (SHA). The document length and detail support this classification with high confidence.
2023-10-04 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.